| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$210,198 ) |
| | 2025 | 2021 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR061445 | The Gut Microbiome and Bone Microarchitecture | 000 | 9 | NIH | 10/29/2024 | $0 |
| | 2025 | 2019 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | RF1AG061221 | Safe Cardiometabolic Drug Prescribing to Prevent Injury in Nursing Home Residents | 000 | 1 | NIH | 10/1/2024 | -$210,198 |
|
| Issue Date FY: 2024 ( Subtotal = $11,513,518 ) |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | 90EJIG0052 | Enhancing Elder Shelter with APS Collaboration, Trauma-Informed Housing Services, and Person-Led Goal-Setting | 00 | 1 | ACL | 8/29/2024 | $475,476 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K24AG070106 | Mentoring Patient-Oriented Research to Prevent Injury in Older Adults | 000 | 4 | NIH | 11/17/2023 | $120,823 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG065299 | Vascular Mechanisms Underlying Skeletal Fragility in Older Adults | 000 | 4 | NIH | 11/24/2023 | $538,606 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG076708 | Multifocal transcranial current stimulation for cognitive and motor dysfunction in dementia | 000 | 3 | NIH | 9/3/2024 | $759,279 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R33AG071744 | NIDUS II: Advanced-Stage Development and Utilization of the NIDUS Research Infrastructure to Advance Interdisciplinary Aging Research in Delirium | 001 | 4 | NIH | 6/28/2024 | $80,540 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R33AG071744 | NIDUS II: Advanced-Stage Development and Utilization of the NIDUS Research Infrastructure to Advance Interdisciplinary Aging Research in Delirium | 000 | 4 | NIH | 2/16/2024 | $724,862 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01HL175560 | Utilization and Clinical Outcomes of Left Atrial Appendage Occlusion in Older Adults with Atrial Fibrillation and Frailty | 000 | 1 | NIH | 6/14/2024 | $722,903 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG081349 | Long-term home-based transcranial electrical stimulation for cognitive and motor function in older adults with an increased risk of dementia: a randomized controlled trial | 000 | 1 | NIH | 8/19/2024 | $1,167,871 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG065265 | Determinants and Outcomes of Age-related Muscle Loss | 001 | 4 | NIH | 6/27/2024 | $758,379 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG065265 | Determinants and Outcomes of Age-related Muscle Loss | 000 | 3 | NIH | 4/15/2024 | $107,947 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG071809 | Applications of Claims-Based Frailty Index to Advance Evidence for Frailty-Guided Decision-Making | 000 | 4 | NIH | 6/21/2024 | $636,192 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K01AG075252 | Modulating brain networks to reduce gait variability in older adults at risk of falling | 000 | 3 | NIH | 12/21/2023 | $112,388 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R56AG084578 | Evaluation of CMS Transitional Care and Chronic Care Management Services: Bridging the Gap and Maximizing Potential | 000 | 1 | NIH | 9/25/2024 | $794,956 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG044518 | BASILÃÂÃÂÃÂÃÂ Better Assessment of Illness: Delirium Severity Measures for Persons with and without Dementia | 000 | 10 | NIH | 6/5/2024 | $689,754 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | T32AG023480 | Harvard Translational Research in Aging Training Program | 001 | 19 | NIH | 7/3/2024 | $525,188 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R03AG088730 | Epidemiology and Long-Term Effect of Cardiometabolic Medication Substitution during Post-acute Care | 000 | 1 | NIH | 9/16/2024 | $318,000 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K24AG073527 | Mid-Career Mentoring Award For Patient-Oriented Research in Frailty and Health Outcomes | 000 | 3 | NIH | 6/26/2024 | $172,477 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR041398 | Novel Molecular Biomarkers of Bone Microarchitecture | 001 | 29 | NIH | 6/13/2024 | $48,536 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K23HL151903 | Risk-Guided Atrial Fibrillation Surveillance in Ischemic Stroke | 000 | 4 | NIH | 7/10/2024 | $163,265 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K01AG083059 | The Effect of the Home Environment on Health and Wellbeing of Low-income Older Adults | 000 | 1 | NIH | 7/26/2024 | $124,875 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG079952 | A randomized, double-blind, placebo-controlled, clinical trial of a probiotic/prebiotic supplement for the dietary management of age-related bone loss. | 000 | 2 | NIH | 5/15/2024 | $657,885 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K23AG066929 | Intensive Palliative Care: Improving the Process of Palliative Ventilator Withdrawal Among Critically Ill Older Adults | 001 | 5 | NIH | 4/17/2024 | $194,400 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG065299 | Vascular Mechanisms Underlying Skeletal Fragility in Older Adults | 001 | 4 | NIH | 5/13/2024 | $59,845 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR041398 | Novel Molecular Biomarkers of Bone Microarchitecture | 000 | 29 | NIH | 4/10/2024 | $624,051 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R37AG032982 | Trial to Reduce Antimicrobial Use in Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD) | 001 | 12 | NIH | 5/6/2024 | $81,016 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R37AG032982 | Trial to Reduce Antimicrobial Use in Nursing home residents with Alzheimer's disease and other Dementias (TRAIN-AD) | 000 | 12 | NIH | 12/14/2023 | $729,130 |
| | 2024 | 2024 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K01AG075180 | Cortical mechanisms and modulation of somatosensation in older adults with foot sole somatosensory impairments | 000 | 3 | NIH | 1/23/2024 | $124,874 |
| | 2024 | 2023 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R03AG072233 | System biology approach to decode molecular mechanism of glucose metabolism in AD and dementia | 000 | 2 | NIH | 6/10/2024 | $0 |
| | 2024 | 2023 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | T32AG023480 | Harvard Translational Research in Aging Training Program | 000 | 18 | NIH | 10/20/2023 | $0 |
| | 2024 | 2023 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR075346 | The Mechanistic Effects of Combined Testosterone Therapy and Exercise on Axial Bone and Muscle Post-Hip Fracture | 000 | 3 | NIH | 6/13/2024 | $0 |
| | 2024 | 2023 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K23AG066929 | Intensive Palliative Care: Improving the Process of Palliative Ventilator Withdrawal Among Critically Ill Older Adults | 000 | 4 | NIH | 10/26/2023 | $0 |
| | 2024 | 2022 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR072199 | Identifying Osteoporosis Genes by Whole Genome Sequencing and Functional Validation in Zebra Fish | 000 | 5 | NIH | 7/24/2024 | $0 |
| | 2024 | 2022 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R21AG073886 | Senolytics to Improve Cognition and Mobility in Older Adults at Risk of Alzheimer’s Disease | 000 | 2 | NIH | 9/20/2024 | $0 |
| | 2024 | 2022 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG059089 | Personalized brain activity modulation to improve balance and cognition in elderly fallers | 000 | 5 | NIH | 6/7/2024 | $0 |
| | 2024 | 2022 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR075356 | Systemic contribution of age-associated epigenetic mechanisms to osteoarthritis | 000 | 4 | NIH | 7/18/2024 | $0 |
| | 2024 | 2022 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AR075356 | Systemic contribution of age-associated epigenetic mechanisms to osteoarthritis | 000 | 4 | NIH | 7/18/2024 | $0 |
| | 2024 | 2022 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | P01AG031720 | Delirium, Dementia, and the Vulnerable Brain: An Integrative Approach | 000 | 10 | NIH | 4/22/2024 | $0 |
| | 2024 | 2021 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG062492 | Nursing Home Prevention of Injury in Dementia (NH PRIDE) | 000 | 3 | NIH | 6/5/2024 | $0 |
| | 2024 | 2020 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | R01AG058539 | ADVANCE: Assessment of Dispariries and Variation for Alzheimer's disease in Nursing home Care at End of Life | 000 | 3 | NIH | 12/13/2023 | $0 |
| | 2024 | 2019 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | RF1AG061221 | Safe Cardiometabolic Drug Prescribing to Prevent Injury in Nursing Home Residents | 001 | 1 | NIH | 8/28/2024 | $0 |
| | 2024 | 2019 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | RF1AG061221 | Safe Cardiometabolic Drug Prescribing to Prevent Injury in Nursing Home Residents | 000 | 1 | NIH | 8/27/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $8,397,283 ) (Continued on the next page) |
| | 2023 | 2023 | HEBREW REHABILITATION CENTER | 1200 CENTRE ST | ROSLINDALE | MA | 02131-1011 | SUFFOLK | USA | K23HL151903 | Risk-Guided Atrial Fibrillation Surveillance in Ischemic Stroke | 001 | 3 | NIH | 8/5/2023 | $167,524 |
| | 2023 | 2023 | HEBREW REHABILITATION CENTER FOR AGED, INC. | 1200 CENTRE ST | BOSTON | MA | 02131-1011 | SUFFOLK | USA | K01AG075252 | Modulating brain networks to reduce gait variability in older adults at risk of falling | 000 | 2 | NIH | 1/9/2023 | $124,875 |
| | 2023 | 2023 | HEBREW REHABILITATION CENTER FOR AGED, INC. | 1200 CENTRE ST | BOSTON | MA | 02131-1011 | SUFFOLK | USA | K01AG075180 | Cortical mechanisms and modulation of somatosensation in older adults with foot sole somatosensory impairments | 000 | 2 | NIH | 1/26/2023 | $124,874 |
| | 2023 | 2023 | HEBREW REHABILITATION CENTER FOR AGED, INC. | 1200 CENTRE ST | BOSTON | MA | 02131-1011 | SUFFOLK | USA | R01AG065299 | Vascular Mechanisms Underlying Skeletal Fragility in Older Adults | 000 | 3 | NIH | 1/5/2023 | $634,272 |
|
